
Keywords: adherence; ezetimibe; low-density lipoprotein cholesterol; secondary prevention; statin therapyACS, acute coronary syndrome(s); CVD, cardiovascular disease; FDC, fixed-dose combination therapy; LDL-C, low-density-lipoprotein cholesterol; MI, myocardial in